Omega Diagnostics Group PLC
15 August 2007
Omega Diagnostics Group PLC
AIM Rule 26 compliant website and change of adviser name
The Company today announces that the information required by Rule 26 of the AIM
Rules for Companies (February 2007) is available within the 'Investor Relations'
section of the Company's website at www.omegadiagnostics.com.
The Company today also announces that, following its change of name from Teather
& Greenwood Limited to Landsbanki Securities (UK) Limited with effect from 9
August 2007, the name of the Company's nominated adviser and broker has changed
to Landsbanki Securities (UK) Limited.
Contacts:
Omega Diagnostics Group PLC
Tel: 01259 763030
Andrew Shepherd, Chief Executive
Kieron Harbinson, Finance Director
www.omegadiagnostics.com
Landsbanki Securities (UK) Limited
Thilo Hoffmann/Simon Brown
Tel: 020 7426 9000
Parkgreen Communications Limited
Lucy Lake
Tel: 020 7479 7933
Mob: 07894 263 046
lucy.lake@parkgreenmedia.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.